Viewing Study NCT04874506


Ignite Creation Date: 2025-12-26 @ 4:02 PM
Ignite Modification Date: 2025-12-30 @ 5:47 AM
Study NCT ID: NCT04874506
Status: UNKNOWN
Last Update Posted: 2021-05-05
First Post: 2021-05-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
Sponsor: Matrix Biomed, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module